Functional Dyspepsia
Functional Dyspepsia is a common digestive condition characterized by discomfort or pain in the upper abdomen, often accompanied by bloating, nausea, and a feeling of fullness after meals.
Functional Dyspepsia: Rikkunshito Study
We are investigating whether Rikkunshito can help relieve symptoms in patients with functional dyspepsia. The study also looks at how it may affect the digestive lining and overall gut function.
3-6 months≤5 visitsConfirmation phase (III)Post-Trial Drug AccessCost ReimbursementInvestigational MedicinesOralGastroenterologyInternal Medicine
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you 18 years old or older?
- Are you currently pregnant, breastfeeding, or planning to become pregnant?
- Do you have diabetes (type 1 or type 2)?
- Do you have an active cancer diagnosis?
- Are you taking any medications that are not allowed in this study, such as certain stomach acid reducers?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Rikkunshito
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
UZLeuven
Gastroenterology
Heverlee, Belgium
Sponsor: UZ Leuven
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.